We are interested in collaborations on neglected infectious diseases, such as Leishmaniasis, Trypanosomiasis and other vector borne diseases traditionally affecting the poorest world population and having recently more impact also in European countries and northern part of the world.
We have competence in the development of pre-clinical projects including drug design, synthetic chemistry, in vitro biological studies, animal model pharmacokinetic and pharmacodynamic studies.
We are available for discussing further details with interested stakeholders.